Brain drain study tracks antibiotic levels in spinal fluid
NCT ID NCT06119061
First seen Jan 07, 2026 · Last updated May 25, 2026 · Updated 23 times
Summary
This study looks at how the antibiotic telavancin moves into the brain fluid of critically ill patients who have had a brain bleed and have a drain in their head. Twenty adults aged 18 to 85 will receive three doses of telavancin, and researchers will measure the drug levels in their blood, brain fluid, and urine. The goal is to understand how much of the drug reaches the brain, not to treat a specific infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBARACHNOID HEMORRHAGE, ANEURYSMAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40536, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.